Seminari e corsi tematici / Seminars and thematic lectures
21st, 28th November and 5th December 2024 Scientific Communication Workshop (from 2:00 to 5:00 pm)
Prof. Brian White, Visiting Professor from UMass Boston
Check the flyer for the full program
24th-25th July 2024 Seminar's series related to Excellence Program
Prof. Marco Ruella, Assistant Professor of Medicine University of Pennsylvania
Check the flyer for the full program
Charting the tumor immune microenvironment to advance immunotherapeutic avenues
Dr Paola Nisticò, Head of Tumor Immunology and Immunotherapy Unit at Department of Research, Advanced Diagnostic and Technological Innovation in the Regina Elena National Cancer Institute, Rome, Italy
8th February 2024 4:00 pm (also available at https://unito.webex.com/meet/paola.cappello )
Q&A "How to build own professional carrier out of Italy" (Meeting Room #2, third floor, Piazza Nizza 44b)
Dr Giulia Adriani, Principal Scientist II, Singapore Immunology Network (SIgN) Agency for Science, Technology and Research (A*STAR) and Adjunct Assistant Professor at the Department of Biomedical Engineering, National University of Singapore (NUS), Singapore
2023-2024 ImmunoPathology Seminars
13 December, 2024 9:00 am JianJian Zhang "PI3Kgamma inhibition in pancreatic cancer"
Dominik Laurentius "New nanomedicine for targeted treatment of ALK+ tumors"
29 November, 2024 9:00 am Antonella Iacoviello "Investigating the role of the cystine/glutamate antiporter xCT in the extracellular vesicle-mediated modulation of the pre-metastatic niche"
Marta Rubin "The role of phosphatases in ALK-mediated transformation and resistance to therapy in ALK-driven tumors"
25 October, 2024 9:00 am Zobia Arshad "Characterization of Teneurin-4 molecular role in cancer"
Florian Jazaj "CAR T cells in pancreatic cancer"
20 September, 2024 5:00 pm Carlesso candidate "TBD"
Federica Autino "Immune suppressive mechanisms induced by tumor microenvironment in multiple myeloma"
19 July, 2024 9:00 am Alessandro Scagliotti, PhD "A novel candidate target for the treatment of pancreatic cancer"
Mariapia Russo "Targeting CCR7-PI3Kgamma axis to overcome resistance to ALK inhibitors in ALK+ lymphoma"
28 June, 2024 9:00 am Giulia Peppino "Teneurin-4 induces doxorubicin resistance through endoplasmic reticulum stress in triple negative breast cancer"
Silvia Brugiapaglia, PhD "A next generation DNA vaccine coding for the immunodominant sequence of alpha-Enolase to treat pancreatic cancer"
31 May, 2024 9:00 am Roberto Ruiu, PhD "Targeting the cystine/glutamate antiporter xCT to induce immunogenic cell death and sensitize mammary cancer cells to immune checkpoint inhibitors"
Ermes Candiello, PhD "Analysis of stromal proteins in pancreatic cancer to block tumor invasion"
19 April, 2024 9:00 am Lidia Tarone, PhD "Harnessing the potential of anti-CSPG4 immunotherapy in combination with standard-of- care for improving osteosarcoma treatment"
TBD
22 March, 2024 5:00 pm Maud Charpentier, PhD “Synergistic effect of SIRPα/CD47 myeloid checkpoint blockade and radiation therapy in breast cancer mouse models”
Rebecca Jones "Targeted therapies and cellular immunotheraphy in hematologic tumors: preclinical and traslational studies”
16 February, 2024 9:00 am Chiara Cossu "STING agonists for the immunotherapy in cancer"
Maria Vittoria Di Marco "Exploiting the inhibition of XPO-1 dependent nuclear export for the treatment of ALK+ tumors"
26 January, 2024 9:00 am Antonino Di Lorenzo "Role of TLRs and xCT in different tumors"
Giulia Mura "Cytoskeleton regulators in T cell lymphoma"
15 December, 2023 9:00 am Valentina Griggio, PhD "Prolonged treatment with ibrutinib modulates phenotypic and functional features of immune cell compartments in chronic lymphocytic leukemia"
Claudia Giannotta, PhD "Daratumumab-induced in vivo immune modulation in relapsed and/refractory multiple myeloma patients treated with Daratumumab-Len-Dex"
24 November, 2023 9:00 am Giuseppina Barutello, PhD "TENM4 exerts a pro tumorigenic role in TNBC"
Giorgia Tiberi "Reshaping tumor microenvironment to enhance DNA vaccine efficacy in pancreatic ductal adenocarcinoma"